Share This Page
Drug Price Trends for FT MOTION SICKNESS
✉ Email this page to a colleague
Average Pharmacy Cost for FT MOTION SICKNESS
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FT MOTION SICKNESS 25 MG TAB | 70677-1088-01 | 0.11933 | EACH | 2024-12-18 |
| FT MOTION SICKNESS 50 MG TAB | 70677-1087-01 | 0.06943 | EACH | 2024-12-18 |
| FT MOTION SICKNESS 50 MG TAB | 70677-1087-01 | 0.08295 | EACH | 2024-11-20 |
| FT MOTION SICKNESS 25 MG TAB | 70677-1088-01 | 0.12136 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Motion Sickness Treatment Market Analysis and Projections
Market Overview
The global motion sickness treatment market is experiencing significant growth, driven by various factors including the increasing number of travelers, advancements in healthcare infrastructure, and the rise in consumer awareness about preventive healthcare.
- Market Size and Growth: As of 2021, the global motion sickness treatment market was valued at $393.7 million and is projected to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031[1][4][5].
Key Drivers of Market Growth
- Increasing Travelers: The rise in the number of travelers, particularly among millennials seeking distinctive and exclusive travel experiences, is a major driver. For instance, in 2022, an estimated 700 million tourists traveled internationally, more than twice the number from the previous year[5].
- Advancements in Healthcare: The integration of innovative technologies such as robotic and AI in the pharmaceutical sector has led to more efficient and cost-effective medications, boosting market growth[2].
- Consumer Awareness: Increased awareness about preventive healthcare and the ease of accessibility of medications have also contributed to the market's expansion[1].
Drug Class Segmentation
- Antihistamines: This segment dominated the market in 2022 due to its cost-effectiveness, over-the-counter availability, and effectiveness in reducing motion sickness. Major players like Sun Pharmaceutical Industries Ltd. and WellSpring Pharmaceutical Corporation offer antihistamine medications, further boosting this segment[1][2].
- Anticholinergics: Expected to grow at the fastest rate during the forecast period, anticholinergics, particularly scopolamine transdermal patches, offer long-lasting relief and better efficacy with fewer side effects. This segment is anticipated to contribute significantly to the market's revenue[1][5].
Route of Administration
- Oral and Transdermal Patches: The market is segmented into oral and other routes of administration. Transdermal patches, known for their user-friendliness and controlled release mechanism, have gained substantial revenue share. These patches provide extended efficacy compared to traditional oral medications[2][3].
Distribution Channels and Regional Outlook
- Distribution Channels: The market is distributed through various channels, including pharmacies, online platforms, and healthcare facilities. The ease of access through these channels has facilitated the adoption of motion sickness medications[3].
- Regional Outlook: North America is expected to witness the highest growth in terms of revenue due to the large population of travelers and increased awareness about motion sickness management. However, the Asia-Pacific region is also anticipated to see significant growth driven by economic growth, urbanization, and initiatives by multinational pharmaceutical corporations[1][3][5].
Impact of COVID-19
The COVID-19 pandemic had a significant impact on the motion sickness treatment market, particularly due to the reduction in international tourist arrivals. However, as travel restrictions are lifted and tourism resumes, the market is expected to recover and expand, with international arrivals projected to return to pre-pandemic levels in the coming years[5].
Technological Advancements and Regulatory Support
- Technological Advancements: Advancements in medication formulations, wearable technologies, and non-pharmacological interventions have contributed to market expansion. Wearable devices offering acupressure or neuromodulation provide drug-free alternatives, appealing to consumers who prefer natural or side-effect-free solutions[4].
- Regulatory Support: Supportive government regulations and approvals have played a crucial role in expanding the market. Regulatory agencies have approved various treatment options, including prescription medications, over-the-counter drugs, and medical devices, making it easier for manufacturers to introduce new products[4].
Key Players
The market is dominated by key players such as Prestige Consumer Healthcare Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Limited, and Novartis AG. These companies are driving the market through the development and marketing of effective motion sickness medications[1][3].
Price Projections and Market Value
- Current Market Value: The global motion sickness treatment market was valued at $393.7 million in 2021[1].
- Projected Market Value: The market is estimated to reach $525 million by 2031, growing at a CAGR of 2.9% from 2022 to 2031[1][4][5].
Key Takeaways
- The global motion sickness treatment market is driven by the increasing number of travelers, advancements in healthcare, and consumer awareness.
- Antihistamines and anticholinergics are the dominant drug classes, with anticholinergics expected to grow at the fastest rate.
- North America and the Asia-Pacific region are key markets, with significant growth anticipated in these regions.
- Technological advancements and regulatory support are crucial for market expansion.
- The market is expected to reach $525 million by 2031, growing at a CAGR of 2.9%.
Frequently Asked Questions (FAQs)
Q: What is the current size of the global motion sickness treatment market? A: The global motion sickness treatment market was valued at $393.7 million in 2021[1].
Q: What is the projected growth rate of the motion sickness treatment market? A: The market is expected to grow at a CAGR of 2.9% from 2022 to 2031[1].
Q: Which drug class dominates the motion sickness treatment market? A: The antihistamines segment dominated the market in 2022 due to its cost-effectiveness and over-the-counter availability[1][2].
Q: What are the key factors driving the growth of the motion sickness treatment market? A: The growth is driven by the increasing number of travelers, advancements in healthcare, and consumer awareness about preventive healthcare[1][2][5].
Q: Which region is expected to witness the highest growth in the motion sickness treatment market? A: North America is expected to witness the highest growth in terms of revenue, followed by significant growth in the Asia-Pacific region[1][3][5].
Cited Sources
- Allied Market Research - Motion Sickness Treatment Market Statistics | Projection - 2031
- GlobeNewswire - Global $481 Million Motion Sickness Treatment Market, 2023-2029
- Transparency Market Research - Motion Sickness Treatment Market Analysis Report 2026
- ResearchAndMarkets - Motion Sickness Treatment Market Size & Forecast to 2030
- Mordor Intelligence - Motion Sickness Treatment Market - Trends & Size
More… ↓
